Cholestyramine
Cholestyramine for Oral Suspension
Approved
Approval ID
b26a13e9-42a2-4869-a00a-672bb1ac4742
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Dec 1, 2023
Manufacturers
FDA
Bryant Ranch Prepack
DUNS: 171714327
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
cholestyramine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code63629-2162
Application NumberANDA077203
Product Classification
M
Marketing Category
C73584
G
Generic Name
cholestyramine
Product Specifications
Route of AdministrationORAL
Effective DateJuly 26, 2022
FDA Product Classification
INGREDIENTS (8)
ASPARTAMEInactive
Code: Z0H242BBR1
Classification: IACT
D&C YELLOW NO. 10Inactive
Code: 35SW5USQ3G
Classification: IACT
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
FD&C RED NO. 40Inactive
Code: WZB9127XOA
Classification: IACT
PROPYLENE GLYCOL ALGINATEInactive
Code: 26CD3J2R0C
Classification: IACT
XANTHAN GUMInactive
Code: TTV12P4NEE
Classification: IACT
CHOLESTYRAMINEActive
Quantity: 4 g in 5 g
Code: 4B33BGI082
Classification: ACTIB
MALTODEXTRINInactive
Code: 7CVR7L4A2D
Classification: IACT